| |
| |
|
| Insider
Information: |
Cantor Maria E |
| Relationship: |
SVP, Investor Rel. & C... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
228,106 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$468,666 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
228,106 |
|
|
| Total
Value |
$468,666 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ariad Pharmaceuticals Inc |
ARIA |
SVP, Corporate Affairs |
2016-03-19 |
135,667 |
|
0 |
Premium* |
|
|
uniQure B.V. |
QURE |
SVP, Investor Rel. & C... |
2018-01-26 |
92,439 |
2017-12-13 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
59 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corporate AffairsOfficer |
• – – |
2012-02-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
7,277 |
|
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corporate Affairs |
• • – |
2015-08-28 |
4 |
AS |
$10.00 |
$12,680 |
D/D |
(1,268) |
107,613 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corporate Affairs and HR |
• • – |
2014-11-24 |
4 |
AS |
$7.00 |
$12,243 |
D/D |
(1,749) |
86,929 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corporate Affairs |
• – – |
2012-06-25 |
4 |
AS |
$17.11 |
$30,199 |
D/D |
(1,765) |
32,337 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corporate Affairs and HR |
• • – |
2014-03-19 |
4 |
D |
$8.19 |
$16,880 |
D/D |
(2,061) |
78,713 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corporate Affairs |
• • – |
2013-03-12 |
4 |
AS |
$22.00 |
$46,310 |
D/D |
(2,105) |
38,568 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corporate Affairs and HR |
• • – |
2014-07-15 |
4 |
D |
$5.57 |
$14,527 |
D/D |
(2,608) |
91,374 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corporate Affairs and HR |
• • – |
2014-09-02 |
4 |
AS |
$6.21 |
$16,753 |
D/D |
(2,696) |
88,678 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corporate Affairs |
• • – |
2015-09-01 |
4 |
AS |
$9.11 |
$24,557 |
D/D |
(2,696) |
104,917 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corporate Affairs |
• – – |
2012-04-03 |
4 |
S |
$16.18 |
$55,027 |
D/D |
(3,400) |
33,327 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corporate Affairs and HR |
• • – |
2015-03-20 |
4 |
AS |
$8.85 |
$31,627 |
D/D |
(3,575) |
101,583 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corporate Affairs |
• – – |
2016-03-19 |
4 |
AS |
$6.46 |
$23,102 |
D/D |
(3,575) |
135,667 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corporate Affairs |
• • – |
2013-03-22 |
4 |
S |
$19.45 |
$71,335 |
D/D |
(3,667) |
42,235 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corporate Affairs and HR |
• • – |
2014-03-21 |
4 |
AS |
$7.89 |
$28,930 |
D/D |
(3,667) |
82,379 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corporate Affairs and HR |
• • – |
2014-06-02 |
4 |
AS |
$6.90 |
$25,611 |
D/D |
(3,713) |
84,461 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corporate Affairs |
• • – |
2015-07-16 |
4 |
AS |
$8.54 |
$34,162 |
D/D |
(4,000) |
108,881 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corporate Affairs and HR |
• • – |
2015-03-23 |
4 |
AS |
$8.55 |
$34,491 |
D/D |
(4,033) |
104,881 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corporate Affairs |
• • – |
2013-04-02 |
4 |
S |
$18.04 |
$76,665 |
D/D |
(4,250) |
62,275 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corporate Affairs and HR |
• • – |
2014-04-02 |
4 |
AS |
$8.21 |
$34,907 |
D/D |
(4,250) |
88,174 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corporate Affairs |
• • – |
2015-09-28 |
4 |
AS |
$6.47 |
$32,327 |
D/D |
(5,000) |
109,917 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corporate Affairs |
• • – |
2012-12-18 |
4 |
D |
$20.18 |
$107,438 |
D/D |
(5,324) |
40,673 |
0 |
- |
|
| QURE |
uniQure B.V. |
SVP, Investor Relations & Comm |
• – – |
2018-01-03 |
4 |
S |
$20.13 |
$118,028 |
D/D |
(5,864) |
85,251 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corporate Affairs |
• • – |
2013-03-22 |
4 |
D |
$19.38 |
$113,896 |
D/D |
(5,877) |
58,025 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corporate Affairs |
• – – |
2012-03-26 |
4 |
OE |
$3.08 |
$18,480 |
D/D |
6,000 |
52,227 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corporate Affairs |
• – – |
2012-03-26 |
4 |
AS |
$16.00 |
$96,000 |
D/D |
(6,000) |
46,227 |
0 |
- |
|
59 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
